Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SDGR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSchrodinger formalizes Chief Commercial Officer departure with separation agreement
Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read
Key Changes
-
medium
Chief Commercial Officer Mannix Aklian separated from the company on June 5, 2026, following a previously disclosed departure. The company entered into a formal separation agreement confirming exit terms.
Item 5.02 verify on EDGAR → -
low
Separation package includes nine months of base salary continuation, 12 months of health insurance premium payments, and $88,096 in prorated bonus payments for work performed in 2026.
Separation Agreement verify on EDGAR → -
low
Restricted stock units scheduled to vest in July 2026 will be accelerated as part of the separation terms. The agreement includes standard release of claims provisions.
Separation Agreement verify on EDGAR →
Summary
Schrodinger formalized the departure of Chief Commercial Officer Mannix Aklian through a separation agreement dated June 5, 2026. The separation was previously disclosed, and this 8-K confirms the final terms of his exit. Aklian led the company's global software sales and marketing efforts, making this a notable leadership change in the commercial organization.
The separation package is relatively standard for an executive departure, consisting of nine months of salary continuation, health benefits, and prorated bonuses totaling $88,096 for time worked in 2026. A modest equity acceleration applies to restricted stock units that were already scheduled to vest in July 2026. The agreement includes typical release of claims provisions.
Retail investors should monitor whether Schrodinger announces a replacement CCO and any potential impact on the company's software sales strategy. Leadership transitions in commercial roles can affect near-term sales execution, particularly if the departure was unexpected or reflects broader strategic shifts.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Transition, Separation and Release of Claims Agreement, dated as of June 5, 2026, by and between Schrödinger, Inc. and Mannix Aklian.
The company entered into a transition, separation and release of claims agreement with Mannix Aklian on June 5, 2026. This type of agreement typically governs the terms of an executive's departure, including severance payments, release of legal claims, and transition responsibilities.
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On June 5, 2026, following the previously disclosed separation of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing of Schrödinger, Inc. (the “Company”), the Company entered into a transition, separation and release of claims agreement (the “Separation Agreement”) with Mr. Aklian, which confirms the terms of his separation from the Company.
The company formalized the departure of its Chief Commercial Officer through a separation agreement on June 5, 2026. This follows a previously announced separation, and the agreement establishes the final terms of his exit including severance payments and benefits.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
salary continuation payments of his monthly base salary, commencing on the first payroll period occurring on or after the day immediately following the Revocation Period (as defined below), and continuing for nine months thereafter, less all applicable taxes and withholdings; and (ii) payment on Mr. Aklian’s behalf of the portion of his COBRA premiums equal to the premiums that the Company pays on behalf of other active, similarly-situated employees for group health and/or dental insurance coverage, if Mr. Aklian timely elects to receive such coverage, for 12 months following Mr. Aklian’s separation from the Company.
The departing CCO will receive nine months of base salary continuation and 12 months of health insurance premium payments. These payments are consistent with the company's standard executive severance plan and his employment agreement terms.
Added in current filing · verify on EDGAR →
payment of a quarterly bonus representing the first quarter of calendar year 2026 worked by Mr. Aklian, less all applicable taxes and withholdings; (iii) a prorated quarterly bonus payment representing the portion of the second quarter of calendar year 2026 worked by Mr. Aklian, less all applicable taxes and withholdings; (iv) a prorated annual bonus payment representing the portion of calendar year 2026 worked by Mr. Aklian, less all applicable taxes and withholdings (the gross amount under prongs (ii) through (iv) of this sentence being equal to $88,096); and (v) acceleration of vesting of the portion of the restricted stock unit award granted to Mr. Aklian in connection with the commencement of his employment that was scheduled to vest in July 2026.
Mr. Aklian will receive $88,096 in prorated bonus payments for work performed in 2026, plus accelerated vesting of restricted stock units that were scheduled to vest in July 2026. These payments represent earned compensation for time worked and a modest equity acceleration.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify